Neuropathy

Patients receiving chemotherapy
#Chemotherapy #Neuropathy #Oncology

Nerve health formulation launches in US to support chemotherapy patients

Novilora has launched in the US, bringing a science-based approach to supporting nerve health for people living through and beyond cancer treatment.   Formulated by Italian internist and oncologist Dr Raffaele Migliaccio and sold in Europe as OnLife, Novilora combines palmitoylethanolamide (PEA) with a defined profile of fatty… Read More

#News

Active nerve cells
#AnHorn Medicines #Chemotherapy #Market reporting #Neuropathy #Phase I trial

Phase I study for prevention of chemotherapy-induced peripheral neuropathy

AnHorn Medicines has dosed the first subject in the Phase I clinical trial of AH-008, a first-in-class neuroprotective candidate being developed to prevent chemotherapy-induced peripheral neuropathy (CIPN). This milestone marks the clinical advancement of a novel therapeutic approach designed to address one of the most common and debilitating complications of… Read More

#News

Cancer cells
#Chemotherapy #Drug discovery #Neuropathy #Oncology

Reducing the side-effects of chemotherapy  

DDW speaks to Yasuo Nakamura, Senior Executive Officer at Pharmaceuticals R&D, Asahi Kasei Pharma Corporation about the challenges of treating chemotherapy-induced peripheral neuropathy (CIPN) and the company’s current pipeline targeting the condition.   DDW: What makes chemotherapy-induced peripheral neuropathy (CIPN) such a persistent challenge in colorectal cancer care, and why has… Read More

#Exclusive Content

#Augustine Therapeutics #Financing #Neuropathy #Spinout

Biotech raises €78 million to advance HDAC6 inhibition therapies

Augustine Therapeutics has raised €78 million to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases. The proceeds from the financing will advance Augustine’s lead candidate, AGT-100216, through a Phase II proof-of-concept clinical trial in Charcot-Marie-Tooth and support significant pipeline expansion.  Jeito Capital, a global independent Private Equity fund, and… Read More

#Business & Investment #News